Date | Name | Shares | Transaction | Value |
Mar 11, 2025
| Daniel J. Mathewes See Remarks |
169,526
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
6,862,412.48
|
Mar 11, 2025
| Erin Day See Remarks |
48,805
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
1,975,626.40
|
Mar 11, 2025
| Erin Day See Remarks |
49,802
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
2,015,984.96
|
Mar 11, 2025
| Carlos Hernandez See Remarks |
14,197
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
574,694.56
|
Mar 11, 2025
| Carlos Hernandez See Remarks |
15,230
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
616,510.40
|
Mar 11, 2025
| Charles Russell Corbin See Remarks |
111,270
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
4,504,209.60
|
Mar 11, 2025
| Charles Russell Corbin See Remarks |
112,362
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
4,548,413.76
|
Mar 11, 2025
| Gordon S. Gurnik See Remarks |
192,731
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
7,801,750.88
|
Mar 11, 2025
| Gordon S. Gurnik See Remarks |
195,632
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
7,919,183.36
|
Mar 11, 2025
| Daniel J. Mathewes See Remarks |
172,422
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
6,979,642.56
|
Mar 11, 2025
| Mark Douglas Wang See Remarks; Director |
774,759
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
31,362,244.32
|
Mar 11, 2025
| Mark Douglas Wang See Remarks; Director |
780,606
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.48 per share |
31,598,930.88
|
Jun 11, 2024
| Gail Mandel Director |
4,537
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
May 15, 2024
| David W. Johnson Director |
52,355
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $42.74 per share |
2,237,652.70
|
May 15, 2024
| David W. Johnson Director |
52,855
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $42.18 per share |
2,229,423.90
|
May 10, 2024
| Paul W. Whetsell Director |
40,205
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
May 10, 2024
| Leonard A. Potter Director |
95,205
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
May 10, 2024
| Brenda J. Bacon Director |
40,630
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
May 10, 2024
| Pamela H. Patsley Director |
35,205
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
May 10, 2024
| Mark H. Lazarus Director |
35,205
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|